We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EIGR
451
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$277K 0.01%
13,133
-937
-7% -$28.9K
XBI icon
452
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$268K 0.01%
130,000
-10,000
-7% -$836K
TDC icon
453
Teradata
TDC
$2.52B
$267K 0.01%
5,000
-5,003
-50% -$226K
SYBX
454
DELISTED
Synlogic
SYBX
$262K 0.01%
40,549
-1,805
-4% -$15.1K
BBIO icon
455
CALL
BridgeBio Pharma
BBIO
$16.3B
$247K 0.01%
93,900
+4,600
+5% +$69.2K
BMEA icon
456
PUT
Biomea Fusion
BMEA
$89.2M
$243K 0.01%
+45,000
New +$1.41M
BGS icon
457
PUT
B&G Foods
BGS
$280M
$243K 0.01%
215,000
+150,000
+231% +$2.16M
ORCL icon
458
Oracle
ORCL
$416B
$237K 0.01%
+1,993
New +$206K
VERA icon
459
CALL
Vera Therapeutics
VERA
$2.34B
$231K ﹤0.01%
+55,000
New +$497K
CHGG icon
460
Chegg
CHGG
$98.5M
$222K ﹤0.01%
25,000
– –
RIG icon
461
PUT
Transocean
RIG
$5.71B
$220K ﹤0.01%
400,000
-85,000
-18% -$525K
MAT icon
462
CALL
Mattel
MAT
$4.25B
$213K ﹤0.01%
+250,000
New +$4.52M
AFMD
463
DELISTED
Affimed
AFMD
$204K ﹤0.01%
+34,090
New +$273K
PFSI icon
464
PUT
PennyMac Financial
PFSI
$4.02B
$168K ﹤0.01%
+110,000
New +$6.97M
AAOI icon
465
CALL
Applied Optoelectronics
AAOI
$11.5B
$165K ﹤0.01%
100,000
– –
MNK
466
DELISTED
Mallinckrodt plc
MNK
$153K ﹤0.01%
129,376
– –
RVLP
467
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$143K ﹤0.01%
254,736
-21,692
-8% -$19.1K
ADT icon
468
PUT
ADT
ADT
$5.64B
$142K ﹤0.01%
35,600
– –
RETA
469
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$133K ﹤0.01%
+16,000
New +$1.51M
BBIO icon
470
PUT
BridgeBio Pharma
BBIO
$16.3B
$126K ﹤0.01%
36,000
-14,000
-28% -$211K
MRSN
471
CALL
DELISTED
Mersana Therapeutics
MRSN
$115K ﹤0.01%
+16,600
New +$2.43M
CNTX icon
472
Context Therapeutics
CNTX
$47.1M
$105K ﹤0.01%
+65,628
New +$55.8K
IWM icon
473
PUT
iShares Russell 2000 ETF
IWM
$82.8B
$104K ﹤0.01%
340,000
-1,890,000
-85% -$337M
MGM icon
474
PUT
MGM Resorts International
MGM
$11.2B
$102K ﹤0.01%
35,000
– –
NVCR icon
475
CALL
NovoCure
NVCR
$1.85B
$101K ﹤0.01%
+22,000
New +$1.37M
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.